Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Upadacitinib improved multiple immune-related conditions in one patient.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Dupilumab users have a higher risk of developing alopecia areata.

Tofacitinib taken by mouth helps treat hair loss in children.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Tofacitinib may help regrow hair in alopecia areata patients.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Co-trimoxazole may help treat autoimmune diseases.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Ixekizumab effectively treats generalized pustular psoriasis.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Upadacitinib effectively treats psoriasis and lichen planus together.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.